ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
8.36
+0.36 (4.44%)
At close: Apr 24, 2026, 4:00 PM EDT
8.21
-0.14 (-1.74%)
After-hours: Apr 24, 2026, 5:01 PM EDT
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $75.59 million as of April 24, 2026. Its market cap has increased by 70.51% in one year.
Market Cap
75.59M
Enterprise Value
84.97M
1-Year Change
70.51%
Ranking
Category
Stock Price
$8.36
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $75.59M, an increase of 3,694.48%. That is a compound annual growth rate of 11.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 75.59M | 35.87% |
| Dec 31, 2025 | 55.63M | 21.22% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 77.38M |
| MAIA Biotechnology | 77.05M |
| aTyr Pharma | 76.98M |
| PMV Pharmaceuticals | 76.79M |
| Pliant Therapeutics | 76.77M |
| XBiotech | 76.52M |
| TScan Therapeutics | 75.73M |
| Fortress Biotech | 75.03M |